INTRODUCTION
Manganese (Mn) is an essential metal in humans that functions in many enzymes, such as pyruvate carboxylase, glutamine synthetase, and numerous peroxidases. 1) In contrast, excessive exposure to Mn results in neurotoxicity. 2) Symptoms of acute Mn toxicity are collectively called manganism, and these symptoms are similar to those seen in patients with Parkinson's disease (PD). 3) Considering that manganism and PD, a dopaminergic cell disorder, are common in many ways and the fact that Mn accumulates in dopaminergic areas, Mn neurotoxicity has been suggested to involve an imbalance in dopaminergic neurotransmission. 4, 5) Neurodegenerative loss of substantia nigra dopaminergic neurons is a known characteristic of PD. While the nature of this neuronal loss is unknown, it is hypothesized that accelerated auto-oxidation of dopamine to quinones and semiquinones accompanied by the generation of reactive oxygen species (ROS) causes direct damage leading to the neuronal loss. 6, 7) This aberrant oxidation could result from increased concentrations of catalytic metals such as iron [Fe(III)] and copper [Cu(II)].
In the body, Fe is mostly bound to proteins such as transferrin in order to regulate its reductionoxidation (redox) activity; however, some Fe is loosely bound to small molecules such as amino acids and other biomolecules. Certain chemicals reduce this unstable Fe(III) to elicit the redox activity of Fe(II). 8) Fe(II) reacts with H 2 O 2 in the Fenton reaction to produce hydroxyl radicals that attack biomolecules. Cu is found in chromosomes and is closely associated with DNA bases. [9] [10] [11] In the presence of Cu(II), catechols such as dopamine are readily oxidized to semiquinones, which are capable of reducing oxygen to produce ROS, such as superoxide anion radicals (O ·− 2 ). The resulting Cu(I) and C 2011 The Pharmaceutical Society of Japan H 2 O 2 reportedly form Cu(I)-OOH, which attacks DNA. 12, 13) This Fe/Cu-mediated oxidative damage may be responsible for the neurodegeneration associated with PD and Alzheimer's disease, 14, 15) although its pathogenic role has not been elucidated. Dopamine-induced oxidative DNA damage or cytotoxicity in the presence of Cu(II) is enhanced by Mn(II). 16, 17) However, in those studies, the di- (8-oxodG) , xanthine oxidase, and 2 -deoxyguanosine (dG) were purchased from Sigma (St. Louis, MO, U.S.A.). Sulfanilic acid and hydroxyl ammonium were obtained from Kanto Chemical Co. (Tokyo, Japan). Calf intestine alkaline phosphatase was obtained from Roche Diagnostics (Mannheim, Germany), Mn(II) chloride (MnCl 2 , 99.9%) was from Nacalai Tesque (Kyoto, Japan), nitrilotriacetate (NTA) was from Dojindo Chemicals (Kumamoto, Japan), H 2 O 2 was from Mitsubishi Gas Chemical Co. (Tokyo, Japan), and horseradish peroxidase (HRP) was obtained from Toyobo Co. (Osaka, Japan). Measurement of 8-oxodG Formation --Reaction mixtures consisting of 10 µM dopamine with or without 10 and 20 µM MnCl 2 in 400 µl of 4 mM sodium phosphate buffer (pH 7.8) were preincubated for 1 hr at 37 • C. Then, calf thymus DNA (100 µM base) and 20 µM CuCl 2 or Fe(NO 3 ) 3 plus NTA [Fe(NO 3 ) 3 : NTA = 1 : 1] were added to the mixtures, followed by incubation for 1 hr at 37 • C. After ethanol precipitation, DNA was digested to nucleosides using nuclease P1 (10 units) and calf intestine alkaline phosphatase (1.3 units); the DNA was then analyzed by high-performance liquid chromatography (HPLC; LC-10 series, Shimadzu, Kyoto, Japan) using an electrochemical detector (ECD; Coulochem II, ESA, Chelmsford, MA, U.S.A.). The HPLC conditions were as follows: column, ODS-80Ts (Tsk-gel, 150 × 4.6 mm i.d.; Tosoh, Tokyo, Japan); column temperature, 25 • C; flow rate, 1 ml/min; and detection wavelength, 254 nm (for dG). The amount of 8-oxodG was determined by ECD analysis. The ECD conditions were as follows: guard cell, 400 mV; channel 1, E 150 mV/R 100 µA/filter 2/output 1 V; channel 2, E 300 mV/R 200 nA/filter 10/output 1 V. Determination of H 2 O 2 Content --The amount of H 2 O 2 was determined by the scopoletin assay. 18, 19) Reaction mixtures consisting of 10 µM dopamine with or without 10 and 20 µM MnCl 2 in 396 µl of 4 mM sodium phosphate buffer (pH 7.0) were preincubated for 1 hr at 37 • C. Thereafter, 4 µl of 2 mM CuCl 2 was added to the reaction mixture, and 80 µl of each reaction mixture was mixed with 50 µl of 42 µM (8 µg/ml) scopoletin and 0.125 units of HRP in 2 ml of 9 mM borate buffer (pH 10.0). Fluorescence intensity was measured using a spectrofluorometer (RF-1500, Shimadzu) with excitation at 397 nm and emission at 460 nm. To measure peroxides other than H 2 O 2 , the mixture, including 10 units of catalase at room temperature, was incubated for 4 min, and its fluorescence intensity was measured.
MATERIALS AND METHODS

Materials
Determination of O ·−
2 Content --Reaction mixtures consisting of 0.8 mM xanthine; 0.8 mM hydroxyl ammonium; 0.1 unit/ml xanthine oxidase; and 0, 10, or 20 µM MnCl 2 with or without 0.1 unit SOD in 0.25 ml of 50 mM sodium phosphate buffer (pH 7.8) were incubated for 10 min at 25 • C. Thereafter, 0.25 ml of 20 mM sulfanilic acid was added, and the mixtures were incubated for 20 min at 25 • C. Then, 0.25 ml of 10 mM N-(1-naphthyl)-ethylenediamine was added and incubated for 20 min at 25 • C. Finally, absorbance at 545 nm was measured with a UV/visible (Vis) spectrophotometer (V-550, Jasco, Tokyo, Japan), and the absorbance of mixtures with SOD was subtracted from that of mixtures without SOD. The O ·− 2 concentration was calculated from the subtracted absorbance using a standard curve. Measurement of Aminochrome Formation --UV spectra of dopamine were recorded using a UV/Vis spectrophotometer (Jasco) at room temper-ature in a measurement cell with a 10-mm path length. Reaction mixtures consisting of 10 µM dopamine, with or without 10 and 20 µM MnCl 2 in 1 ml of 4 mM sodium phosphate buffer (pH 7.8), were preincubated for 1 hr at 37 • C, and their UV spectra were recorded at 20-min intervals. After adding 20 µM CuCl 2 to the reaction mixtures, their UV spectra were obtained at 5-min intervals for 30 min and then at 10-min intervals for another 150 min. Statistical Analysis --Student's t-test was performed to evaluate the significance between the two groups. A value of p < 0.05 was considered significant.
RESULTS
Mn(II)-dependent Enhancement of 8-oxodG Formation Induced by Fe(III)-NTA/Cu(II) and Dopamine
First, the effect of Mn(II) on 8-oxodG formation induced by Fe(III)-NTA/Cu(II) and dopamine was investigated. 8-oxodG formation increased significantly in the presence of Fe(III)-NTA/Cu(II) and dopamine; however, it did not increase in the presence of Fe(III)-NTA, Cu(II), or dopamine alone (Fig. 1) . Although Mn(II) did not induce 8-oxodG formation in the presence or absence of dopamine, the Fe(III)-NTA/Cu(II)-mediated oxidative DNA damage by dopamine increased significantly after adding Mn(II). The increasing effect of Mn(II) on the Cu(II)-mediated oxidative DNA damage was more effective than that on the Fe(III)-NTA-mediated damage. 
Effect of Mn(II) on the Time Course of H 2 O 2 Production in the DNA-damaging System
The effect of Mn(II) was investigated on the time course of H 2 O 2 production in the DNAdamaging system consisting of dopamine and Cu(II). In the absence of Mn(II), H 2 O 2 production was detected 20 min after addition of Cu(II) and reached a maximum at 45 min (Fig. 2) . However, in the presence of 10 or 20 µM Mn(II), H 2 O 2 production was detected at 15 or 10 min, respectively, and was maximum at 20 min. (Fig. 3) . Mn(II) did not inhibit xanthine oxidase activity based on the production of uric acid, a final oxidized product of xanthine 
Mn(II)-dependent
Mn(II)-dependent Promotion of Cu(II)-mediated Dopamine Oxidation
The effect of Mn(II) on the dopamine redox reaction with Cu(II) was determined by UV spectrophotometry.
Dopamine is oxidized to aminochrome, which shows maximum absorption at 490 nm. 20) Absorption at 490 nm increased with increasing Mn(II) concentration (Fig. 4) . Mn(II)-dependent aminochrome formation was dramatically promoted in the presence of Cu(II).
DISCUSSION
We demonstrated that Mn(II) enhances 8-oxodG formation and accelerates H 2 O 2 production and provided with the first evidence that Mn(II) decreases the O ·− 2 generated in the DNA damaging system. These data strongly suggest that Mn(II) enhances oxidative DNA damage through SOD-like activity that converts O ·− 2 to H 2 O 2 , which is involved in the DNA damage mediated by Fe(III)/Cu(II) and catechol compounds. The enhancing effect of SOD on the DNA damage induced by Cu(II) and H 2 O 2 has been reported. 21 16) We showed for the first time that Mn(II) enhanced the oxidative DNA damage induced by Cu(II) more effectively than that induced by Fe(III)-NTA in the presence of dopamine. Cu(II) is closely located to DNA, and its reduced form Cu(I) tightly binds to DNA and introduces a conformational change. 24) The bound Cu(I) anchors the H 2 O 2 that attacks DNA by forming a DNA-Cu(I)-OOH complex. 16) In contrast, Fe(III)-NTA provides hydroxyl radicals far from DNA. Therefore, the accelerated supply of H 2 O 2 by Mn(II) may have enhanced the DNA damage in the Cu(II)-dopamine system compared to that in the Fe(III)-NTA.
Some crosstalk through transporters occurs during metal metabolism. Divalent metal transporter 1 (DMT1) is one of the transporter proteins for divalent metals including Mn(II), Cu(II), and Fe(II). Exposure to Mn(II) induces DMT1 upregulation and increases intracellular Fe concentration. 4, 25) Increased DMT1 expression and Fe accumulation were observed in an animal model of PD treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). A mutation that impairs DMT1 function protects animals from the neurotoxins MPTP and 6-hydroxydopamine. 26) Increased Cu and Mn contents were observed in rat corpus striatum after quinolinate intrastriatal injection. 27) Together with these findings, the combined action of Mn with Fe/Cu demonstrated in the present study may contribute to Mn-induced neurodegenerative Parkinsonism.
